AG003K53

485799-04-0 | 4-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)morpholine

AG003K53

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	485799-04-0
Catalog Number	AG003K53(AGN-PC-0KL7H6)
Chemical Name	4-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)morpholine
IUPAC Name	4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]morpholine
InChI	InChI=1S/C15H23BN2O3/c1-14(2)15(3,4)21-16(20-14)12-5-6-13(17-11-12)18-7-9-19-10-8-18/h5-6,11H,7-10H2,1-4H3
InChI Key	ZGDLVKWIZHHWIR-UHFFFAOYSA-N
MDL Number	MFCD04039874
Molecular Formula	C15H23BN2O3
Molecular Weight	290.1657
SMILES	CC1(C)C(C)(C)OB(C2=CN=C(N3CCOCC3)C=C2)O1
Synonyms	485799-04-0, 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)morpholine, 4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]morpholine, 6-(Morpholin-4-yl)pyridine-3-boronic acid pinacol ester, 2-Morpholinopyridine-5-boronic acid, pinacol ester, 4-[5-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-yl]-morpholine, MFCD04039874, AK-44367, 4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]morpholine, 6-Morpholinopyridin-3-ylboronic acid pinacol ester, 2-(4-Morpholino)pyridine-5-boronic acid pinacol ester, 4-[5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]morpholine, PubChem17161, AC1Q2CSX, AC1Q2CSY, AC1MDT79, AMTB158, SCHEMBL142528, AMTB1031, CTK8E2411, DTXSID90383637, ZGDLVKWIZHHWIR-UHFFFAOYSA-N, ZXBA000304, KS-00000K4O, ZX-AT017751, AKOS015960091, ZINC169743692, AB17430, AM86992, AS-2721, CM-2029, CS-W003923, MCULE-7005007340, OR14006, QC-2555, RP00106, TRA0003047, ACM485799040, AN-28038, BC000429, AB0008880, AX8028837, ST2417985, FT-0677600, A-6490, A22216, C-1542, 771T629, A827561, J-513572, 6-MORPHOLINOPYRIDINE-3-BORONIC ACID PINACOL ESTER, (6-MORPHOLINOPYRIDIN-3-YL)BORONIC ACID PINACOL ESTER, 6-(Morpholin-4-yl)pyridine-3-boronic acid pinacol ester, 97%, 2-(MORPHOLIN-4-YL)PYRIDINE-5-BORONIC ACID PINACOL ESTER, 4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridyl]morpholine, 4-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-yl]morpholine, 4-[5-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)pyridin-2-yl]-morpholine, 4-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyridin-2-yl]morpholine, 4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridin-2-yl]morpholine, 4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-yl]morpholine, C15H23BN2O2S, C15H23BN2O3, 6- pyridine-3-boronicacidpinacolester, CID2795363, 6-(4-MORPHOLINYL)PYRIDINE-3-BORONIC ACID PINACOL ESTER, 4-(5-(4.4.5.5.-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)thiomorpholine, 1352413-75-2, 494771-62-9,

Complexity	356
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	290.18g/mol
Formal Charge	0
Heavy Atom Count	21
Hydrogen Bond Acceptor Count	5
Hydrogen Bond Donor Count	0
Isotope Atom Count	0
Molecular Weight	290.17g/mol
Monoisotopic Mass	290.18g/mol
Rotatable Bond Count	2
Topological Polar Surface Area	43.8A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code	\N

Certificate of Analysis

Lot Number